Search - tctmd.com

Displaying 21 - 39 of 39

Sort: Relevancy | Date

News Daily News

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Yael L. Maxwell

April 17, 2017

Presentation TCT 2016

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman

October 30, 2016

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

$The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond$

Presentation TCT 2015

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Presenter: Robert A. Byrne, Stefan K. James, Paul S. Teirstein

October 11, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

Presentation TCT 2014

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Paul S. Teirstein

September 14, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

News Daily News

Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent

September 05, 2012

News Daily News

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

September 05, 2012

Presentation

Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 (Re-188) for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis

Presenter: Martin Werner

August 31, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

Robot-Assisted PCI Shows Promise in Early Clinical Experience

Caitlin E. Cox

April 29, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

Advertisement

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 (Re-188) for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Robot-Assisted PCI Shows Promise in Early Clinical Experience

Therapies Take on In-Stent Restenosis with Mixed Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content